secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2022-10-26T23:59:59+00:00
Accession:  0001558370-22-015396
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health Q3 revenue up 17% to $611.4M; net loss narrows to $73.5M
-----------------------------------------------------------------------

- Q3 revenue $611.4M (+17% YoY); net loss $73.5M ($0.45/sh) vs $84.3M loss prior year.
- Adjusted EBITDA $51.2M, above high end of guidance; operating cash flow $63.0M.
- Nine-month 2022 net loss $9.85B driven by non-cash goodwill impairment; revenue $1.77B (+20%).
- CEO Jason Gorevic cited strong quarter and progress on whole-person care strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022015396/0001558370-22-015396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022015396/tdoc-20221026x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-015396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer